Literature DB >> 8943161

Clinical and biochemical abnormalities in people heterozygous for hemochromatosis.

Z J Bulaj1, L M Griffen, L B Jorde, C Q Edwards, J P Kushner.   

Abstract

BACKGROUND: Ten percent of whites are heterozygous for the HLA-linked hemochromatosis mutation. We performed a cross-sectional analysis of 1058 genotyped heterozygotes to define the effects of age and sex on the phenotype.
METHODS: The heterozygous genotype was assigned to 505 male and 553 female members of 202 pedigrees, each with an HLA-typed homozygous proband. We measured serum iron, transferrin saturation, and ferritin in all heterozygotes and in 321 genetically normal subjects (unaffected family members or spouses of family members). Liver biopsies were performed in a subgroup of heterozygotes.
RESULTS: The mean serum iron concentrations and transferrin-saturation values were higher in heterozygotes than in normal subjects and did not increase with age. Initial transferrin-saturation levels exceeding the threshold associated with the homozygous genotype were found in 4 percent of male and 8 percent of female heterozygotes. The geometric mean serum ferritin concentration was higher in heterozygotes than in normal subjects and increased with age. Higher-than-normal values were found in 20 percent of male and 8 percent of female heterozygotes. The clinical and biochemical expression of hemochromatosis was more marked in heterozygotes with paternally transmitted mutations than in those with maternally transmitted mutations. Liver-biopsy abnormalities were generally associated with alcohol abuse, hepatitis, or porphyria cutanea tarda.
CONCLUSIONS: The phenotype of persons heterozygous for hemochromatosis differs from that of normal subjects, but complications due to iron overload alone in these heterozygotes are extremely rare.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943161     DOI: 10.1056/NEJM199612123352403

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  38 in total

1.  Should we genetically test everyone for haemochromatosis?

Authors:  K Allen; R Williamson
Journal:  J Med Ethics       Date:  1999-04       Impact factor: 2.903

2.  Reference distributions for serum iron and transferrin saturation: a comparison of a large cohort to the world's literature.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia; Thomas B Ledue; Wendy Y Craig
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

3.  A method for detecting recent selection in the human genome from allele age estimates.

Authors:  Christopher Toomajian; Richard S Ajioka; Lynn B Jorde; James P Kushner; Martin Kreitman
Journal:  Genetics       Date:  2003-09       Impact factor: 4.562

4.  The origin and spread of the HFE-C282Y haemochromatosis mutation.

Authors:  S Distante; K J H Robson; J Graham-Campbell; A Arnaiz-Villena; P Brissot; Mark Worwood
Journal:  Hum Genet       Date:  2004-09       Impact factor: 4.132

5.  Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis.

Authors:  Justin P Rubio; Melanie Bahlo; Niall Tubridy; Jim Stankovich; Rachel Burfoot; Helmut Butzkueven; Caron Chapman; Laura Johnson; Mark Marriott; Grant Mraz; Brian Tait; Chris Wilkinson; Bruce Taylor; Terence P Speed; Simon J Foote; Trevor J Kilpatrick
Journal:  Hum Genet       Date:  2004-03-11       Impact factor: 4.132

6.  Nuclear gamma-resonance electron paramagnetic dialysis: implications for experimental biology and medicine.

Authors:  L A Piruzyan; A L Piruzyan
Journal:  Dokl Biol Sci       Date:  2004 Jul-Aug

Review 7.  The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.

Authors:  Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2017-11-13       Impact factor: 2.490

8.  Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan.

Authors:  Tsung-Jung Lin; Chih-Lin Lin; Chaur-Shine Wang; Shu-O Liu; Li-Ying Liao
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

9.  The significance of haemochromatosis gene mutations in the general population: implications for screening.

Authors:  M J Burt; P M George; J D Upton; J A Collett; C M Frampton; T M Chapman; T A Walmsley; B A Chapman
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

10.  High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis.

Authors:  D A McClain; D Abraham; J Rogers; R Brady; P Gault; R Ajioka; J P Kushner
Journal:  Diabetologia       Date:  2006-03-15       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.